Tag Archives: canbank venture capital fund

Canbank Venture Capital Fund Ltd picks up Minority Stake in Unlisted Rs 200 Cr, M/s Him Teknoforge Ltd

* CVCFL invest Rs. 30 crore in HIM Teknoforge for a minority Equity stake. * HIM Teknoforge to use funds for its Capital Expenditure plans.

Mumbai, India, April 19th, 2016 — Continuing its strategy of investing in unlisted companies with high growth potential Canbank Venture Capital Fund Ltd. (CVCFL) through its Emerging India Growth Fund, has picked up a minority equity stake in ‘Him Teknoforge Ltd’ (HIM) for a consideration of Rs 30 crore which includes Rs 7.80 Cr towards partial buyout of Equity shareholding held by IFCI Venture Capital Funds Ltd. HIM is a leading manufacturer of Forgings and Machined Components for end use in Agri-Machinery, Automotives, Railways, Defense and Oil & Gas sectors. The product range comprises of gears, axles, shafts, levers, flanges, assemblies, sub assemblies, non gear/spider kits, etc.

Explaining the reason for investing in the company, Mr. K Baskaran, Managing Director, Canbank Venture Capital Fund Ltd. (CVCFL) said, “The Company envisages good business potential in widening its product and customer base by undertaking modernization-cum-technology upgradation and expansion at its existing plants. The proposed capex will help the company in meeting the demands of its existing customers for the Machined Components. This will enhance the value addition of HIM’s operations.” He further added, HIM being an established player in the Industry will get the inherent benefits of the same.

The Indian forging industry has emerged as a major contributor to the manufacturing sector of the Indian Economy, estimated at more than USD 3 billion currently, and approx. 20-25% of the size of the forging industry is attributed to exports. HIM has a good, progressive management which will take the company to greater heights.

States Mr. Rajiv Aggarwal, Executive Director, HIM, “We have been looking for funds to expand/upgrade our operations to achieve the full capacities of the units and also to enhance the Product value/ branding besides increasing our share of business from the existing customers as well adding new Customers.”. He further adds that “HIM is able to offer competitive prices due to its presence in excise-free zone at Baddi (HP) and proximity to major manufacturers of Tractors and commercial vehicles who constitute about 75% of the company’s business “. The funds from CVFCL shall be deployed towards modernization/additional plant and machinery and tools & dies at its existing forging and machining units.

HIM has come to be a name of repute over a period of time for its cutting edge technology, established quality processes, and overall engineering capabilities. The Company is playing a significant role in the agri-machinery , automobile and engineering industry. HIM has completely integrated facilities including in-house quality assurance and testing infrastructure.

HIM caters to major OEM Clients which includes Mahindra & Mahindra Ltd., Escorts Ltd., International Tractors,, Preet Agro, AVTEC, Indo Farm Industries & others in Agricultural sector and Ashok Leyland, SML-Isuzu, Bharat Gears, VE Commercials, Oerlikon Group, in Automotive Sector besides Indian Railways & Defense. HIM is persistently expanding its customer base and recently the company has added other prominent customers namely ZF Steering, Brakes India, which will add to the revenues and improve the bottom-line.

The company is planning an IPO sometime in the next 2-3 years. http://www.himteknoforge.com/

Press & Media Contact:
Mitesh M Kapadia
Sentinel Public Relations Pvt Ltd / Sentinel Advertising Services
B-603, Samajdeep
Near Bhanu Park/Seasons Restaurant
Adukia Road, Off S V Road
Kandivli (W), Mumbai 400 067. INDIA
Tel: (91 22) 28625131/32
Cel: +91 98205 03876
Fax: (91 22) 28625133
mitesh@publicrelationindia.com
http://www.publicrelationindia.com
http://www.canbankventure.com

Canbank Venture Capital Fund (CVCFL) Picks Up Stake in Bioneeds India Pvt. Ltd., (Bioneeds) Bengaluru

* Bioneeds is a OECD GLP certified and AAALAC accredited Pre-Clinical Contract Research Organization with 1,10,000 SFT of world class Vivarium and supporting laboratories at Bengaluru.
* Bioneeds has strong research oriented scientific manpower of 150 people.
* Bioneeds services highly reputed Indian and International Pharmaceutical, Biotech, Agrochemical, Medical Devices, Nutraceuticals, Cosmetics and Industrial chemical companies.
* Bioneeds will deploy funds in the ensuing expansion plan to broaden its service offerings which would include Discovery, Development and Regulatory service under one roof for pharma, biotech, agrochemical and medical device companies.
* Bioneeds has highly skilled scientific manpower of 150 people, several of them with Phd./Doctoral Research to their credit.

Mumbai, India, December 24th, 2015 — Canbank Venture Capital Fund Ltd (CVCFL) through its Fifth Fund viz., Emerging India Growth Fund has invested Rs.250 Million by way equity shares and convertibles for a minority stake in M/s Bioneeds India Private Limited (Bioneeds).

Total expansion program will lead to addition of 120,000 Sq ft of facility, of which 55,000 Sq Ft will be added immediately. This will result in total 230000 Sq ft facility consisting of Biopharma discovery labs (Molecular Biology, Cell Culture, Upstream and Downstream, DPD, Bioanalytical and QC labs). NEC discovery labs (Chemistry, DMPK, Safety Pharmacology, Bioanalytical and Canine Facility) and also additional manpower of 75 scientists. With this expansion, Bioneeds will be offering full range of Discovery, Development and Regulatory services to Pharma, Biotech, Medical Device and Agrochemical companies.

Mr S Thiruvadi, Managing Director, Canbank Venture Capital Fund Ltd. (CVCFL) said, “Globally, Indian Scientific Community is highly respected for their ingenuity, professionalism and contribution they have done in the field of new Drug Discovery. Also, they have created positive impact in other industries in which Bioneeds offer their services. High-quality scientific manpower coupled with cost advantage of India, is a compelling business reason for many international companies to outsource their research work in India. Bioneeds has demonstrated this and is very well positioned to capture the growth opportunity with their well-qualified scientific manpower. The EBITDA and PAT margins from Bioneeds are good and CVCFL anticipates that Bioneeds with their strong customer base and progressive professional management will achieve high growth in the revenues and profitability and be able to offer significant returns through dividends and capital appreciation on exit. CVCFL from its fund EIGF has been assisting unlisted mid stage/late stage companies in the manufacturing and services sector with good growth potential and require funding”

According to independent reports, global R&D expenditure for the pharmaceutical industry in 2014 was about US$ 139 billion with significant potential for outsourcing. Penetration of outsourcing to independent CROs is estimated to be at CAGR of about 12.5%. Parameters like high quality Scientific manpower and cost advantage places India in a comfortable position to capture this business. World class facility and well established processes are additional requirements, which Bioneeds has rightly identified.

States Dr. S.N. Vinaya Babu, MD, Bioneeds, “we are a first-generation business built primarily on high quality work by our well qualified scientific staff. Our high-growth till date has been funded by internal accruals and borrowings. We have been actively looking for funds to strengthen our balance sheet and also expand our services. The funds from CVCFL shall be deployed to build additional Vivarium and Discovery Labs with state-of-the-art equipments. This will help us to broaden our service offerings and deepen our relationship with 250+ active customers we currently service. We aim to be counted among the best Global CROs offering complete range of services. We aim to become INR 1,000 million Company in next 3 years.”

Press & Media Contact:
Mitesh M Kapadia
Sentinel Public Relations Pvt Ltd / Sentinel Advertising Services
B-603, Samajdeep, Near Bhanu Park/Seasons Restaurant
Adukia Road, Off S V Road
Kandivli (W), Mumbai 400 067 India
Mob: +91 98205 03876
Tel: (022) 28625131/32
Fax: (022) 28625133
mitesh@publicrelationindia.com
http://www.publicrelationindia.com
http://www.canbankventure.com